Senior Principal Scientist / Associate Director, Toxicology
Orum Therapeutics
About this role
A Senior Principal Scientist / Associate Director in nonclinical toxicology for Degrader-Antibody Conjugate (DAC) programs. The role focuses on designing, executing, and interpreting nonclinical safety studies and contributing to regulatory submissions.
Skills
Qualifications
About Orum Therapeutics
orumrx.comOrum Therapeutics is a biotechnology company developing cell‑specific, targeted protein degraders that combine the selectivity of antibody targeting with the mechanism of targeted protein degradation. Their platform aims to selectively eliminate disease‑relevant proteins in defined cell types, expanding the druggable proteome while improving therapeutic precision and safety. Orum advances proprietary degrader therapeutics and works with partners to translate its technology into new treatments.
About Orum Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Orum Therapeutics.